ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial.

Herzog TJ, Krivak TC, Bush S, Diaz JP, Lentz S, Nair N, Zgheib NB, Gunderson-Jackson C, Barve A, Denning KL, Lirette ST, Howard CM, Valluri J, Claudio PP.

Open source

DOI: 10.1038/s41698-025-00874-0
Published: 2025-03-25
Container: NPJ Precis Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-025-00874-0,
  title = {ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial.},
  author = {Herzog TJ and  Krivak TC and  Bush S and  Diaz JP and  Lentz S and  Nair N and  Zgheib NB and  Gunderson-Jackson C and  Barve A and  Denning KL and  Lirette ST and  Howard CM and  Valluri J and  Claudio PP.},
  year = {2025},
  journal = {NPJ Precis Oncol},
  doi = {10.1038/s41698-025-00874-0},
  url = {https://doi.org/10.1038/s41698-025-00874-0}
}

RIS

TY  - JOUR
TI  - ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial.
AU  - Herzog TJ
AU  -  Krivak TC
AU  -  Bush S
AU  -  Diaz JP
AU  -  Lentz S
AU  -  Nair N
AU  -  Zgheib NB
AU  -  Gunderson-Jackson C
AU  -  Barve A
AU  -  Denning KL
AU  -  Lirette ST
AU  -  Howard CM
AU  -  Valluri J
AU  -  Claudio PP.
PY  - 2025
JO  - NPJ Precis Oncol
DO  - 10.1038/s41698-025-00874-0
UR  - https://doi.org/10.1038/s41698-025-00874-0
ER  -

APA

TJ, H., TC, K., S, B., JP, D., S, L., N, N., NB, Z., C, G., A, B., KL, D., ST, L., CM, H., J, V., & PP., C. (2025). ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial.. NPJ Precis Oncol. https://doi.org/10.1038/s41698-025-00874-0

Source records

europe-pmc · retrieved 2026-09-25T18:41:28.416Z
doaj · retrieved 2026-09-25T18:41:28.431Z